These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37241204)

  • 41. Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: systematic review and meta-analysis.
    Srivastava A; Nogueras Gonzalez GM; Geng Y; Won AM; Cabanillas ME; Naing A; Myers JN; Li Y; Chambers MS
    Support Care Cancer; 2021 May; 29(5):2305-2317. PubMed ID: 33190182
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is serum C-terminal telopeptide cross-link of type 1 collagen a reliable parameter for predicting the risk of medication-related osteonecrosis of the jaws? A systematic review and meta-analysis of diagnostic test accuracy.
    Traboulsi-Garet B; Jorba-García A; Camps-Font O; Alves FA; Figueiredo R; Valmaseda-Castellón E
    Clin Oral Investig; 2022 Mar; 26(3):2371-2382. PubMed ID: 35124731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of evidence in reducing risk of MRONJ after teeth extractions with systemic antibiotics.
    Cabras M; Gambino A; Broccoletti R; Sciascia S; Arduino PG
    J Oral Sci; 2021; 63(3):217-226. PubMed ID: 34193777
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dental Implant Placement in Patients With a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review.
    Sher J; Kirkham-Ali K; Luo JD; Miller C; Sharma D
    J Oral Implantol; 2021 Jun; 47(3):249-268. PubMed ID: 32699903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab.
    Wick A; Bankosegger P; Otto S; Hohlweg-Majert B; Steiner T; Probst F; Ristow O; Pautke C
    Clin Oral Investig; 2022 Mar; 26(3):2839-2852. PubMed ID: 34812959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of Medication-Related Osteonecrosis of the Jaw (MRONJ) Using Leukocyte- and Platelet-Rich Fibrin (L-PRF) and Photobiomodulation: A Retrospective Study.
    Tenore G; Zimbalatti A; Rocchetti F; Graniero F; Gaglioti D; Mohsen A; Caputo M; Lollobrigida M; Lamazza L; De Biase A; Barbato E; Romeo U
    J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33138266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis.
    Schoenhof R; Munz A; Yuan A; ElAyouti A; Boesmueller H; Blumenstock G; Reinert S; Hoefert S
    J Craniomaxillofac Surg; 2021 Jun; 49(6):508-517. PubMed ID: 33707134
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of platelet-rich fibrin in the surgical treatment of medication-related osteonecrosis of the jaw: 40 patients prospective study.
    Zelinka J; Blahak J; Perina V; Pacasova R; Treglerova J; Bulik O
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2021 Sep; 165(3):322-327. PubMed ID: 32597421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists.
    Mauceri R; Coniglio R; Abbinante A; Carcieri P; Tomassi D; Panzarella V; Di Fede O; Bertoldo F; Fusco V; Bedogni A; Campisi G
    Support Care Cancer; 2022 Aug; 30(8):6429-6440. PubMed ID: 35292850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medication-related osteonecrosis of the jaw: Surgical or non-surgical treatment?
    Favia G; Tempesta A; Limongelli L; Crincoli V; Maiorano E
    Oral Dis; 2018 Mar; 24(1-2):238-242. PubMed ID: 29480596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ).
    Pichardo SEC; van der Hee JG; Fiocco M; Appelman-Dijkstra NM; van Merkesteyn JPR
    Br J Oral Maxillofac Surg; 2020 Sep; 58(7):771-776. PubMed ID: 32631756
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature.
    Del Fabbro M; Gallesio G; Mozzati M
    Eur J Cancer; 2015 Jan; 51(1):62-74. PubMed ID: 25466505
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stage-specific therapeutic strategies of medication-related osteonecrosis of the jaws: a systematic review and meta-analysis of the drug suspension protocol.
    Ramaglia L; Guida A; Iorio-Siciliano V; Cuozzo A; Blasi A; Sculean A
    Clin Oral Investig; 2018 Mar; 22(2):597-615. PubMed ID: 29332231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Management of medication-related osteonecrosis of the jaw-a review of recent study results in comparison to established strategies].
    Tröltzsch M; Tröltzsch M; Pautke C; Otto S
    HNO; 2022 Jul; 70(7):499-507. PubMed ID: 35050392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative Segmentation Analysis of the Radiological Changes by Using ITK-SNAP: Risk Assessment of the Severity and Recurrence of Medication-related Osteonecrosis of the Jaw.
    Zhou YQ; Son GH; Shi YQ; Yu YJ; Li MY; Zhang Q; Zou DH; Zhang ZY; Yang C; Wang SY
    Int J Med Sci; 2021; 18(10):2209-2216. PubMed ID: 33859529
    [No Abstract]   [Full Text] [Related]  

  • 56. Autologous Platelet Concentrates (APCs) for Hard Tissue Regeneration in Oral Implantology, Sinus Floor Elevation, Peri-Implantitis, Socket Preservation, and Medication-Related Osteonecrosis of the Jaw (MRONJ): A Literature Review.
    Mijiritsky E; Assaf HD; Kolerman R; Mangani L; Ivanova V; Zlatev S
    Biology (Basel); 2022 Aug; 11(9):. PubMed ID: 36138733
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the Jaw.
    Allegra A; Innao V; Pulvirenti N; Musolino C
    Tohoku J Exp Med; 2019 May; 248(1):27-29. PubMed ID: 31080196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medication-related osteonecrosis of the jaws and quality of life: review and structured analysis.
    Murphy J; Mannion CJ
    Br J Oral Maxillofac Surg; 2020 Jul; 58(6):619-624. PubMed ID: 32247520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.
    Hauer L; Jambura J; Hrusak D; Chalupova M; Posta P; Rusnak S; Vyskocil V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):100-107. PubMed ID: 30647474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Laser and Platelet-Rich Plasma to treat Medication-Related Osteonecrosis of the Jaws (MRONJ): a case report.
    Fornaini C; Cella L; Oppici A; Parlatore A; Clini F; Fontana M; Lagori G; Merigo E
    Laser Ther; 2017 Sep; 26(3):223-227. PubMed ID: 29133970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.